Montag & Caldwell, LLC Edwards Lifesciences Corp Transaction History

Montag & Caldwell, LLC

$490 Million
Q3 2024

A detailed history of Montag & Caldwell, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Montag & Caldwell, LLC holds 101,191 shares of EW stock, worth $6.86 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

101,191

Previous 184,550 45.17%

Holding current value

$6.86 Million

Previous $17 Million 60.83%

% of portfolio

1.36%

Previous 3.45%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$59.7 - $93.78 $4.98 Million - $7.82 Million	-83,359 Reduced 45.17%	101,191 $6.68 Million
Q2 2024 Aug 09, 2024	SELL	$84.3 - $94.31 $3.95 Million - $4.42 Million	-46,850 Reduced 20.25%	184,550 $17 Million
Q1 2024 May 01, 2024	BUY	$72.54 - $95.56 $1.04 Million - $1.37 Million	14,333 Added 6.6%	231,400 $22.1 Million
Q4 2023 Feb 05, 2024	SELL	$61.71 - $77.76 $9.92 Million - $12.5 Million	-160,811 Reduced 42.56%	217,067 $16.6 Million
Q3 2023 Nov 03, 2023	BUY	$69.28 - $93.38 $5.04 Million - $6.79 Million	72,686 Added 23.82%	377,878 $26.2 Million
Q2 2023 Aug 07, 2023	SELL	$81.41 - $94.33 $275,247 - $318,929	-3,381 Reduced 1.1%	305,192 $28.8 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $47,600 - $54,170	-641 Reduced 0.21%	308,573 $25.5 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $8.08 Million - $10.3 Million	118,346 Added 62.0%	309,214 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $7.89 Million - $10.3 Million	95,740 Added 100.64%	190,868 $15.8 Million
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $7.96 Million - $11.8 Million	-91,986 Reduced 49.16%	95,128 $9.05 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $203,920 - $256,680	-2,000 Reduced 1.06%	187,114 $22 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $2.43 Million - $2.99 Million	-22,880 Reduced 10.79%	189,114 $24.5 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $626,824 - $747,670	-6,091 Reduced 2.79%	211,994 $24 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $1.04 Million - $1.31 Million	-12,464 Reduced 5.41%	218,085 $22.6 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $14.4 Million - $16.6 Million	-183,165 Reduced 44.27%	230,549 $19.3 Million
Q4 2020 Feb 02, 2021	BUY	$71.69 - $91.23 $1.03 Million - $1.32 Million	14,434 Added 3.62%	413,714 $37.5 Million
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $576,557 - $750,322	-8,581 Reduced 2.1%	399,280 $31.9 Million
Q2 2020 Aug 03, 2020	BUY	$57.54 - $76.95 $13.8 Million - $18.5 Million	239,898 Added 142.83%	407,861 $28.2 Million
Q1 2020 May 01, 2020	SELL	$52.41 - $81.0 $1.22 Million - $1.89 Million	-23,289 Reduced 12.18%	167,963 $31.7 Million
Q4 2019 Feb 03, 2020	SELL	$71.7 - $82.09 $653,688 - $748,414	-9,117 Reduced 4.55%	191,252 $44.6 Million
Q3 2019 Nov 04, 2019	SELL	$61.55 - $75.43 $203,484 - $249,371	-3,306 Reduced 1.62%	200,369 $44.1 Million
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $226,694 - $261,955	-4,067 Reduced 1.96%	203,675 $37.6 Million
Q1 2019 May 01, 2019	SELL	$47.89 - $64.05 $860,726 - $1.15 Million	-17,973 Reduced 7.96%	207,742 $39.7 Million
Q4 2018 Feb 01, 2019	SELL	$46.41 - $56.94 $6.48 Million - $7.95 Million	-139,635 Reduced 38.22%	225,715 $34.6 Million
Q3 2018 Nov 01, 2018	SELL	$45.7 - $58.03 $9.35 Million - $11.9 Million	-204,555 Reduced 35.89%	365,350 $63.6 Million
Q2 2018 Aug 01, 2018	SELL	$42.45 - $51.3 $15.5 Million - $18.7 Million	-364,863 Reduced 39.03%	569,905 $83 Million
Q1 2018 May 02, 2018	BUY	$37.19 - $47.45 $1.37 Million - $1.75 Million	36,873 Added 4.11%	934,768 $130 Million
Q4 2017 Feb 01, 2018	SELL	$33.79 - $39.39 $3.24 Million - $3.77 Million	-95,835 Reduced 9.64%	897,895 $101 Million
Q3 2017 Nov 01, 2017	BUY	$36.29 - $38.83 $36.1 Million - $38.6 Million	993,730	993,730 $109 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag & Caldwell, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Montag & Caldwell, LLC with notifications on news.

Account

Montag & Caldwell, LLC Edwards Lifesciences Corp Transaction History